Renata Ciccarelli Selected Research

Guanosine

1/2021	Investigating the Role of Guanosine on Human Neuroblastoma Cell Differentiation and the Underlying Molecular Mechanisms.
1/2015	Guanosine protects glial cells against 6-hydroxydopamine toxicity.
2/2009	Guanosine improves motor behavior, reduces apoptosis, and stimulates neurogenesis in rats with parkinsonism.
1/2007	Guanosine inhibits CD40 receptor expression and function induced by cytokines and beta amyloid in mouse microglia cells.
11/2006	Guanosine effect on cholesterol efflux and apolipoprotein E expression in astrocytes.
4/2004	Guanosine protects SH-SY5Y cells against beta-amyloid-induced apoptosis.
12/2003	Guanosine promotes myelination and functional recovery in chronic spinal injury.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Renata Ciccarelli Research Topics

Disease

6	Neoplasms (Cancer) 12/2021 - 01/2018
4	Glioblastoma (Glioblastoma Multiforme) 12/2019 - 09/2015
4	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2018 - 01/2007
3	Neuroblastoma 01/2021 - 04/2004
3	Alzheimer Disease (Alzheimer's Disease) 01/2018 - 01/2007
2	Glioma (Gliomas) 01/2017 - 11/2006
1	Breast Neoplasms (Breast Cancer) 12/2021
1	Insulin Resistance 12/2021
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 12/2021
1	Wounds and Injuries (Trauma) 01/2019
1	Brain Injuries (Brain Injury) 01/2018
1	Lesch-Nyhan Syndrome (Choreoathetosis Self Mutilation Hyperuricemia Syndrome) 01/2018
1	Hypoxia (Hypoxemia) 01/2017
1	Brain Neoplasms (Brain Tumor) 09/2015
1	Seizures (Absence Seizure) 09/2009
1	Absence Epilepsy (Childhood Absence Epilepsy) 09/2009
1	Parkinsonian Disorders (Parkinsonism) 02/2009
1	Stroke (Strokes) 05/2007
1	Brain Ischemia (Cerebral Ischemia) 05/2007
1	Pheochromocytoma 06/2005
1	Gliosis 09/2004
1	Spinal Injuries (Spinal Injury) 12/2003

Drug/Important Bio-Agent (IBA)

7	GuanosineIBA 01/2021 - 12/2003
4	Adenosine (Adenocard)FDA LinkGeneric 01/2021 - 05/2007
4	PurinesIBA 01/2021 - 01/2018
4	EnzymesIBA 01/2021 - 01/2017
3	Adenosine Triphosphate (ATP)IBA 01/2021 - 01/2019
2	Pharmaceutical PreparationsIBA 12/2021 - 01/2007
2	Proteins (Proteins, Gene)FDA Link 02/2021 - 01/2021
2	Tumor Biomarkers (Tumor Markers)IBA 02/2021 - 01/2021
2	GuanineIBA 01/2021 - 01/2018
2	3'-O-(4-benzoyl)benzoyladenosine 5'-triphosphateIBA 12/2019 - 01/2019
2	purineIBA 01/2018 - 01/2017
2	Amyloid beta-PeptidesIBA 01/2015 - 04/2004
2	Neuroprotective AgentsIBA 01/2015 - 11/2006
1	Cyclic NucleotidesIBA 12/2021
1	diethylstilbestrol monophosphate (PDES)IBA 12/2021
1	Biological ProductsIBA 12/2021
1	Phosphoric Diester Hydrolases (Phosphodiesterases)IBA 12/2021
1	Adenosine A1 ReceptorIBA 12/2021
1	LipidsIBA 01/2021
1	Adenine FDA LinkGeneric 01/2021
1	Purine NucleosidesIBA 01/2021
1	Nucleic AcidsIBA 01/2021
1	Purinergic P2X7 ReceptorsIBA 12/2019
1	Transforming Growth Factors (Transforming Growth Factor)IBA 12/2019
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2018
1	Hypoxanthine Phosphoribosyltransferase (Hypoxanthine Guanine Phosphoribosyltransferase)IBA 01/2018
1	Acetylcholine (Acetylcholine Chloride)FDA Link 01/2018
1	NucleosidesIBA 01/2017
1	Purine-Nucleoside PhosphorylaseIBA 01/2017
1	LigandsIBA 09/2015
1	Purinergic Receptors (Receptors, Purine)IBA 09/2015
1	Temozolomide (Temodar)FDA LinkGeneric 09/2015
1	Oxidopamine (6 Hydroxydopamine)IBA 01/2015
1	Purinergic P1 Receptors (Adenosine Receptor)IBA 09/2009
1	Proteasome InhibitorsIBA 02/2009
1	Glycogen Synthase Kinase 3 betaIBA 05/2007
1	Glutamic Acid (Glutamate)FDA Link 05/2007
1	CholesterolIBA 11/2006
1	Nerve Growth Factor (NGF)IBA 06/2005
1	Glial Fibrillary Acidic ProteinIBA 09/2004

Therapy/Procedure

3	Therapeutics 12/2021 - 09/2015
2	Drug Therapy (Chemotherapy) 12/2021 - 01/2018
1	Investigational Therapies (Experimental Therapy) 01/2007